Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II randomized double-blind study of HRS-2129 for postoperative orthopedic pain
CTR20250144Phase 2Completed
- Sponsor
- Shandong Sende
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-2129 in acute pain, sponsored by Shandong Sende. Started Mar 2025; status: completed.
02
Drugs
HRS-2129
03
Conditions
acute pain
Beyond the preview
Go deeper on CTR20250144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250144.